Loading…
Drug-induced endocrine and metabolic disorders
Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic...
Saved in:
Published in: | Drug safety 2007-01, Vol.30 (3), p.215-245 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3 |
container_end_page | 245 |
container_issue | 3 |
container_start_page | 215 |
container_title | Drug safety |
container_volume | 30 |
creator | MA, Ronald C. W KONG, Alice P. S CHAN, Norman TONG, Peter C. Y CHAN, Juliana C. N |
description | Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment. |
doi_str_mv | 10.2165/00002018-200730030-00005 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_19665902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A200343983</galeid><sourcerecordid>A200343983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</originalsourceid><addsrcrecordid>eNptkMtKAzEUhrNQbK2-ggyI7qbmMrnMsniHghtdh0xypkTmUpOZhW9vakeLYM4i8PP94eRDKCN4SYngNzgdionKKcaSYcxwvov4EZpjQoqcl0TM0GmM7ylVVKgTNCOSFWnwHC3vwrjJfedGCy6DzvU2-A4y07mshcFUfeNt5nzsg4MQz9BxbZoI59O9QG8P96-3T_n65fH5drXObVGQIXeKFICp4NyUxklZMVoTW4EkteVMlrgCsJIRbqAiVBVWUkwtcOGIcljVbIGu9-9uQ_8xQhx066OFpjEd9GPUpBSCl5gm8HIPbkwD2nd1PwRjd7BeJSHpk6ViiVr-Q6Vx0Hrbd1D7lP8pqH3Bhj7GALXeBt-a8KkJ1jvt-ke7_tX-HfFUvZhWH6sW3KE4OU_A1QSYaE1TB9NZHw-cEpxKytkXn3uJQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19665902</pqid></control><display><type>article</type><title>Drug-induced endocrine and metabolic disorders</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>MA, Ronald C. W ; KONG, Alice P. S ; CHAN, Norman ; TONG, Peter C. Y ; CHAN, Juliana C. N</creator><creatorcontrib>MA, Ronald C. W ; KONG, Alice P. S ; CHAN, Norman ; TONG, Peter C. Y ; CHAN, Juliana C. N</creatorcontrib><description>Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.</description><identifier>ISSN: 0114-5916</identifier><identifier>DOI: 10.2165/00002018-200730030-00005</identifier><identifier>PMID: 17343430</identifier><language>eng</language><publisher>Auckland: Adis international</publisher><subject>Biological and medical sciences ; Calcium Metabolism Disorders - chemically induced ; Drug toxicity and drugs side effects treatment ; Drug-Related Side Effects and Adverse Reactions ; Endocrine System Diseases - chemically induced ; Endocrine System Diseases - diagnosis ; Gonadal Disorders - chemically induced ; Humans ; Medical sciences ; Metabolic Diseases - chemically induced ; Metabolic Diseases - diagnosis ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Thyroid Diseases - chemically induced ; Water-Electrolyte Imbalance - chemically induced</subject><ispartof>Drug safety, 2007-01, Vol.30 (3), p.215-245</ispartof><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2007 Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</citedby><cites>FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18652725$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17343430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MA, Ronald C. W</creatorcontrib><creatorcontrib>KONG, Alice P. S</creatorcontrib><creatorcontrib>CHAN, Norman</creatorcontrib><creatorcontrib>TONG, Peter C. Y</creatorcontrib><creatorcontrib>CHAN, Juliana C. N</creatorcontrib><title>Drug-induced endocrine and metabolic disorders</title><title>Drug safety</title><addtitle>Drug Saf</addtitle><description>Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.</description><subject>Biological and medical sciences</subject><subject>Calcium Metabolism Disorders - chemically induced</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Drug-Related Side Effects and Adverse Reactions</subject><subject>Endocrine System Diseases - chemically induced</subject><subject>Endocrine System Diseases - diagnosis</subject><subject>Gonadal Disorders - chemically induced</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Metabolic Diseases - chemically induced</subject><subject>Metabolic Diseases - diagnosis</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Thyroid Diseases - chemically induced</subject><subject>Water-Electrolyte Imbalance - chemically induced</subject><issn>0114-5916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNptkMtKAzEUhrNQbK2-ggyI7qbmMrnMsniHghtdh0xypkTmUpOZhW9vakeLYM4i8PP94eRDKCN4SYngNzgdionKKcaSYcxwvov4EZpjQoqcl0TM0GmM7ylVVKgTNCOSFWnwHC3vwrjJfedGCy6DzvU2-A4y07mshcFUfeNt5nzsg4MQz9BxbZoI59O9QG8P96-3T_n65fH5drXObVGQIXeKFICp4NyUxklZMVoTW4EkteVMlrgCsJIRbqAiVBVWUkwtcOGIcljVbIGu9-9uQ_8xQhx066OFpjEd9GPUpBSCl5gm8HIPbkwD2nd1PwRjd7BeJSHpk6ViiVr-Q6Vx0Hrbd1D7lP8pqH3Bhj7GALXeBt-a8KkJ1jvt-ke7_tX-HfFUvZhWH6sW3KE4OU_A1QSYaE1TB9NZHw-cEpxKytkXn3uJQw</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>MA, Ronald C. W</creator><creator>KONG, Alice P. S</creator><creator>CHAN, Norman</creator><creator>TONG, Peter C. Y</creator><creator>CHAN, Juliana C. N</creator><general>Adis international</general><general>Wolters Kluwer Health, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TK</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20070101</creationdate><title>Drug-induced endocrine and metabolic disorders</title><author>MA, Ronald C. W ; KONG, Alice P. S ; CHAN, Norman ; TONG, Peter C. Y ; CHAN, Juliana C. N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Calcium Metabolism Disorders - chemically induced</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Drug-Related Side Effects and Adverse Reactions</topic><topic>Endocrine System Diseases - chemically induced</topic><topic>Endocrine System Diseases - diagnosis</topic><topic>Gonadal Disorders - chemically induced</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Metabolic Diseases - chemically induced</topic><topic>Metabolic Diseases - diagnosis</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Thyroid Diseases - chemically induced</topic><topic>Water-Electrolyte Imbalance - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MA, Ronald C. W</creatorcontrib><creatorcontrib>KONG, Alice P. S</creatorcontrib><creatorcontrib>CHAN, Norman</creatorcontrib><creatorcontrib>TONG, Peter C. Y</creatorcontrib><creatorcontrib>CHAN, Juliana C. N</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MA, Ronald C. W</au><au>KONG, Alice P. S</au><au>CHAN, Norman</au><au>TONG, Peter C. Y</au><au>CHAN, Juliana C. N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-induced endocrine and metabolic disorders</atitle><jtitle>Drug safety</jtitle><addtitle>Drug Saf</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>30</volume><issue>3</issue><spage>215</spage><epage>245</epage><pages>215-245</pages><issn>0114-5916</issn><abstract>Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.</abstract><cop>Auckland</cop><pub>Adis international</pub><pmid>17343430</pmid><doi>10.2165/00002018-200730030-00005</doi><tpages>31</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0114-5916 |
ispartof | Drug safety, 2007-01, Vol.30 (3), p.215-245 |
issn | 0114-5916 |
language | eng |
recordid | cdi_proquest_miscellaneous_19665902 |
source | Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List |
subjects | Biological and medical sciences Calcium Metabolism Disorders - chemically induced Drug toxicity and drugs side effects treatment Drug-Related Side Effects and Adverse Reactions Endocrine System Diseases - chemically induced Endocrine System Diseases - diagnosis Gonadal Disorders - chemically induced Humans Medical sciences Metabolic Diseases - chemically induced Metabolic Diseases - diagnosis Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Thyroid Diseases - chemically induced Water-Electrolyte Imbalance - chemically induced |
title | Drug-induced endocrine and metabolic disorders |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A12%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-induced%20endocrine%20and%20metabolic%20disorders&rft.jtitle=Drug%20safety&rft.au=MA,%20Ronald%20C.%20W&rft.date=2007-01-01&rft.volume=30&rft.issue=3&rft.spage=215&rft.epage=245&rft.pages=215-245&rft.issn=0114-5916&rft_id=info:doi/10.2165/00002018-200730030-00005&rft_dat=%3Cgale_proqu%3EA200343983%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19665902&rft_id=info:pmid/17343430&rft_galeid=A200343983&rfr_iscdi=true |